Evidence map›Paper›PMID 24632842›Full record

ArticlePloS one2014

Comparative genome analysis of Lactobacillus rhamnosus clinical isolates from initial stages of dental pulp infection: identification of a new exopolysaccharide cluster.

Mangala A Nadkarni, Zhiliang Chen, Marc R Wilkins, Neil Hunter

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Quantification and gene expression ofThe Saudi dental journal · 2021
    Article
  6. Ribosome-EngineeredApplied and environmental microbiology · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Members of theMicroorganisms · 2019
    Review
  12. Article
  13. Complete genome sequence ofGut pathogens · 2018
    Article
  14. Selective persistence of Propionibacterium species FMA5 following sealing of infected dentinal matrix.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Systems Biology of Microbial Exopolysaccharides Production.Frontiers in bioengineering and biotechnology · 2015
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mangala A NadkarniInstitute of Dental Research, Westmead Centre for Oral Health and Westmead Millennium Institute, Westmead, New South Wales, Australia; Faculty of Dentistry, The University of Sydney, Sydney, New South Wales, Australia.
Zhiliang ChenSystems Biology Initiative, School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, New South Wales, Australia.
Marc R WilkinsSystems Biology Initiative, School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, New South Wales, Australia.
Neil HunterInstitute of Dental Research, Westmead Centre for Oral Health and Westmead Millennium Institute, Westmead, New South Wales, Australia; Faculty of Dentistry, The University of Sydney, Sydney, New South Wales, Australia.

Funding

Molecular Analysis of Infection in Advanced CariesR01DE015272 · NIDCR · INSTITUTE OF DENTAL RESEARCH · PI HUNTER, NEIL · 2005 to 2008
$826k
NIDCR NIH HHS R01 DE015272NIDCR NIH HHS R01 DE015272-07
6 · The paper itself

Abstract

The human oral microbiome has a major role in oral diseases including dental caries. Our studies on progression of caries infection through dentin and more recently, the invasion of vital dental pulp, detected Lactobacillus rhamnosus in the initial stages of infection of vital pulp tissue. In this study employing current high-throughput next generation sequencing technology we sought to obtain insight into genomic traits of tissue invasive L. rhamnosus, to recognise biomarkers that could provide an understanding of pathogenic potential of lactobacilli, generally regarded as safe. Roche GS FLX+ technology was used to generate whole genome sequences of two clinical isolates of L. rhamnosus infecting vital pulp. Detailed genome-wide comparison of the genetic profiles of tissue invasive L. rhamnosus with probiotic L. rhamnosus was performed to test the hypothesis that specific strains of L. rhamnosus possessing a unique gene complement are selected for the capacity to invade vital pulp tissue. Analysis identified 264 and 258 genes respectively, from dental pulp-invasive L. rhamnosus strains LRHMDP2 and LRHMDP3 isolated from two different subjects that were not present in the reference probiotic L. rhamnosus strain ATCC 53103 (GG). Distinct genome signatures identified included the presence of a modified exopolysaccharide cluster, a characteristic confirmed in a further six clinical isolates. Additional features of LRHMDP2 and LRHMDP3 were altered transcriptional regulators from RpoN, NtrC, MutR, ArsR and zinc-binding Cro/CI families, as well as changes in the two-component sensor kinase response regulator and ABC transporters for ferric iron. Both clinical isolates of L. rhamnosus contained a single SpaFED cluster, as in L. rhamnosus Lc705, instead of the two Spa clusters (SpaCBA and SpaFED) identified in L. rhamnosus ATCC 53103 (GG). Genomic distance analysis and SNP divergence confirmed a close relationship of the clinical isolates but segregation from the reference probiotic L. rhamnosus strain ATCC 53103 (GG).

Indexed as

Bacterial AdhesionBacterial ProteinsDental PulpGenomicsHumansLacticaseibacillus rhamnosusPolysaccharides, BacterialBacterial ProteinsPolysaccharides, Bacterial

Identifiers

PMID24632842
PMCPMC3954586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.